Posted by: lopchandai March 16, 2014
Login in to Rate this Post:
0 
? 
?
Yah I saw Zgnx tanked. You know it's not not easy to get market share from the established companies when the market is so big. The market for chronic pain is more than $500 billion. Even if Zohydro can penetrate 1% of the market, ZGNX will have huge increase in their revenue. I am very positive that zohydro gonna perform well. All these pharmas are scared of Zgnx at the moment because Zohydro is strongest among them without acetaminophen. Overdose of acetaminophen can mess up liver really bad resulting in death.
Even the FDA's chief has come out and defended the approval of Zohydro saying, "drug’s benefits in treating chronic pain treat pain should outweigh fears of its potential for abuse."
The FDA points out there's a large need for pain medications in the United States. The Institute of Medicine says about 100 million adult Americans suffer chronic pain every year, and the cost to the nation is between $560 billion and $635 billion annually.(Copied from NBCNEWS)
One of the senators, Joe Manchin has involved personally by introducing a bill to reverse the FDA's decision. But I don't believe this bill will go any further. His daughter is CEO of Mylan Inc that claims to be the third largest generics and specialty pharmaceutical company in the world. He might lose his senate seat in the next election because of this favoritism.
Recently, there have been so many negative news, but I see the sell off as an opportunity to buy the stock at discounted price. I am long ZGNX and will keep it forever.
Even the FDA's chief has come out and defended the approval of Zohydro saying, "drug’s benefits in treating chronic pain treat pain should outweigh fears of its potential for abuse."
The FDA points out there's a large need for pain medications in the United States. The Institute of Medicine says about 100 million adult Americans suffer chronic pain every year, and the cost to the nation is between $560 billion and $635 billion annually.(Copied from NBCNEWS)
One of the senators, Joe Manchin has involved personally by introducing a bill to reverse the FDA's decision. But I don't believe this bill will go any further. His daughter is CEO of Mylan Inc that claims to be the third largest generics and specialty pharmaceutical company in the world. He might lose his senate seat in the next election because of this favoritism.
Recently, there have been so many negative news, but I see the sell off as an opportunity to buy the stock at discounted price. I am long ZGNX and will keep it forever.